Jamaica Plain, MA1 Active Studies

Substance Use Disorder Clinical Trials in Jamaica Plain, MA

Find 1 actively recruiting substance use disorder clinical trials in Jamaica Plain, MA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
20
Enrolling

Recruiting Substance Use Disorder Studies in Jamaica Plain

About Substance Use Disorder Clinical Trials in Jamaica Plain

Substance use disorder is a condition where the use of substances leads to health issues, disability, and failure to meet responsibilities. It encompasses alcohol, opioid, stimulant, and other drug addictions. Treatment includes behavioral therapy, medication-assisted treatment, and support programs.

There are currently 1 substance use disorder clinical trials recruiting participants in Jamaica Plain, MA. These studies are seeking a combined 20 participants. Research is being sponsored by Brigham and Women's Hospital. Clinical trial participation is free and participants receive study-related medical care at no cost.

Substance Use Disorder Clinical Trials in Jamaica Plain — FAQ

Are there substance use disorder clinical trials in Jamaica Plain?

Yes, there are 1 substance use disorder clinical trials currently recruiting in Jamaica Plain, MA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Jamaica Plain?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Jamaica Plain research site will contact you about next steps.

Are clinical trials in Jamaica Plain free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Jamaica Plain studies also compensate for your time and travel.

What substance use disorder treatments are being tested?

The 1 active trials in Jamaica Plain are testing new therapies including novel drugs, biologics, and treatment approaches for substance use disorder.

Data updated October 18, 2026 from ClinicalTrials.gov